Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Roundup Safety Data Relied on by EPA is Flawed and Outdated, Scientists Says August 21, 2015 Irvin Jackson Add Your CommentsTwo prominent doctors are calling for federal regulators to review the safety of Roundup and other glyphosate-based herbicides, indicating that new information about the potential risks to human health make the data previously relied on by the U.S. Environmental Protection Agency (EPA) outdated.ย The EPA has previously given glyphosate a clean bill of health in the past, but the doctors indicate that the agency relied on flawed Roundup safety data.In an editorial in the New England Journal of Medicine on August 26, the two doctors, Philip J. Landrigan and Charles Benbrook, raised questions about the overall safety of genetically modified organisms (GMOs) and crops, and called for a new assessment of Roundup and glyphosate.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONIn March, the International Agency for Research on Cancer (IARC), an arm of the World Health Organization (WHO), announced that it had determined that the herbicide glyphosate probably causes cancer in humans. The designation has raised questions about the safety of the worldโs most popular weed killer, Monsantoโs Roundup, and outraged the agricultural industry giant.The EPA announced in April that it plans to address the safety concerns of glyphosate during the regular EPA safety review hearingย atย some point in the near future.Monsanto has said that the IARCโs conclusions were agenda-driven and based on โjunk science,โ and has said it is convening its own independent panel to review the cancer risks of Roundup, which is the most widely used weed killer in the world.Landrigan, the Dean for Global Health at Mount Sinai Medical Center in New York and a leading pediatrician, and Benbrook, who works as an adjunct professor in the crops and soil science department at Washington State University, warn that glyphosate is overused in the U.S. and there is mounting evidence that it is unsafe. What’s more, they say that Monsanto’s creation of herbicide-resistant crops, then marketed as “Roundup Ready” has made the U.S. overly reliant on their products.“These ‘Roundup-Ready’ crops now account for more than 90% of the corn and soybeans planted in the United States. Their advantage, especially in the first years after introduction, is that they greatly simplify weed management,” the doctors noted. “But widespread adoption of herbicide-resistant crops has led to overreliance on herbicides and, in particular, glyphosate.”The doctors note that glyphosate use in the U.S. has increased by a factor of more than 350, from 0.4 million kilograms (kg) to 113 million kg from 1974 to 2014. Global use has increased tenfold.“[T]he National Toxicology Program should urgently assess the toxicology of pure glyphosate, formulated glyphosate, and mixtures of glyphosate and other herbicides,” they wrote.Of particular concern to the doctors was last year’s EPA approval of Enlist Duo, a new formulation of glyphosate which includes the chemical 2,4-D, which was a component in the Agent Orange defoliant used during the Vietnam War which has sense been linked to a number of illnesses that affected veterans of that conflict.The doctors called the science behind the EPA’s approval flawed and noted that 2, 4-D is listed as a possible human carcinogen, and now glyphosate is considered a probable human carcinogen, raising serious questions about the safety of Enlist Duo. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, GMOs, Monsanto, Roundup Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14873964648/in/photolist-oEmXum-oEn9ki-oWRbVK-oEmWnm-oWzFRi-oWPp5q-oEmvVY-oEmahn-oEmb2Z-r4HEKx-qrgbpD-qr3Syo-qrgb6x-r4HT7B-qrg5px-r6sNDC-rnWUhU-rnV1kP-qr3DSm-rnWEWf-qrfS4a-qk19Pd-argEhZ-7xtMSn-ettS6G-qk2CQb-qnhf96-pqi9cy-8CVPxp-pqwwpc-smqxZX-sjb3fb-7xtMYM-q5QsjF-rinfWJ-qndT8S-pqwisv-pqhREq-qndxjo-qn6XWT-q5Hp19-q5JaP9-q5J8Wm-q5HsUG-qngP1k-qn6VRF-fj2VwZ-cnzyy9-seffn5-rV4Khp">Mike Mozart via Flickr</a> Creative CommonsMore Roundup Lawsuit Stories U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings June 25, 2026 Roundup Class Action Lawsuit Linked to $7.2B NHL Settlement Transferred to Federal MDL June 2, 2026 MDL Judge Urged To Block $7.25B Roundup Non-Hodgkinโs Lymphoma Settlement April 28, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (Posted: today)C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026) Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (Posted: yesterday)A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.MORE ABOUT: DUPIXENT LAWSUITCTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026) Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (Posted: 2 days ago)Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Over Spinal Cord Stimulator Removal Claims Device Caused Numbness, Incontinence (08/06/2026)Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (07/31/2026)Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)
Nearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (Posted: today)C.R. Bard and its Becton Dickinson parent company face more than 3,700 Bard PowerPort lawsuits that claim the port catheters are defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)
Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (Posted: yesterday)A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.MORE ABOUT: DUPIXENT LAWSUITCTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)Dupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026)
Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (Posted: 2 days ago)Manufacturer wants the Judicial Panel on Multidistrict Litigation to reject a proposal by a group of plaintiffs to consolidate all federal Abbott spinal cord stimulator lawsuits.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITLawsuit Over Spinal Cord Stimulator Removal Claims Device Caused Numbness, Incontinence (08/06/2026)Spine Stimulator Injury Lawyers Seek Leadership Roles in Boston Scientific MDL (07/31/2026)Spinal Cord Stimulator Reprogramming Caused Electric Shocks, Worsening Pain: Lawsuit (07/27/2026)